Foghorn Therapeutics (FHTX) Earnings Date & Reports

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FHTX is expected to report earnings to rise 6.23% to -31 cents per share on August 12

Foghorn Therapeutics FHTX Stock Earnings Reports

Q2'25

Est.

$-0.32

Q1'25

Missed

by $0.11

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.12

Q2'24

Beat

by $0.19

The last earnings report on May 14 showed earnings per share of -30 cents, missing the estimate of -18 cents. With 60.82K shares outstanding, the current market capitalization sits at 234.67M.

View a ticker or compare two or three

Compare

FHTX